rs797045599
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_020988.3(GNAO1):c.680C>T(p.Ala227Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A227A) has been classified as Likely benign.
Frequency
Consequence
NM_020988.3 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 17Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- movement disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- neurodevelopmental disorder with involuntary movementsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNAO1 | NM_020988.3 | c.680C>T | p.Ala227Val | missense_variant | Exon 6 of 9 | ENST00000262493.12 | NP_066268.1 | |
| GNAO1 | NM_138736.3 | c.680C>T | p.Ala227Val | missense_variant | Exon 6 of 8 | NP_620073.2 | ||
| GNAO1 | XM_011523003.4 | c.554C>T | p.Ala185Val | missense_variant | Exon 6 of 9 | XP_011521305.1 | ||
| GNAO1 | XR_007064866.1 | n.1427C>T | non_coding_transcript_exon_variant | Exon 6 of 9 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461174Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726920
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 17 Pathogenic:3
- -
- -
PS3,PS2,PM2,PP3 -
Genetic developmental and epileptic encephalopathy Pathogenic:1
- -
Developmental and epileptic encephalopathy Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GNAO1 function (PMID: 28747448). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNAO1 protein function. ClinVar contains an entry for this variant (Variation ID: 211088). This missense change has been observed in individual(s) with early onset epileptic encephalopathy (PMID: 25966631). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 227 of the GNAO1 protein (p.Ala227Val). -
Developmental and epileptic encephalopathy, 17;C4479569:Neurodevelopmental disorder with involuntary movements Pathogenic:1
- -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30838255, 27072799, 25966631, 28747448, 28202424, 28628939, 27787898, 32382396, 33298085, 27535533) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at